Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Use of Text Messages to Improve Care For Children Following an ED Visit for Asthma

20. november 2017 opdateret af: Children's Hospitals and Clinics of Minnesota

BACKGROUND Asthma is a prevalent and troublesome pediatric condition. In 2013, Emergency Department (ED) providers treated over 3,500 cases of asthma-related complaints at Children's Hospitals and Clinics of Minnesota. Pediatric ED visits for asthma exceeds billions of dollars annually when including direct cost and lost productivity. Many of these visits and resultant costs are avoidable. Patients with well-controlled asthma do not typically exhibit these patterns, while patients with poorly controlled asthma show patterns of increased utilization of healthcare resources and lower quality of life. Evidence suggests that a text message reminder and educational program might positively influence pediatric asthma care practices.

RESEARCH QUESTION Does a targeted ED based text message intervention program improve outpatient follow-up and routine preventive care in pediatric asthma patients?

METHODS Study subjects will be block randomized based on age and insurance group. The experimental group will receive text messages with guidance towards follow-up care with their PCP and the importance of the flu vaccine for children with asthma. The control group will receive a series of educational self-care and health based text messages unrelated to asthma or the flu vaccine. Some self-report of behaviors will be captured via text message response.

ANALYSIS Primary outcomes for the educational versus targeted text message groups will be compared use Chi-square tests. Additional adjustments may be applied for missing data or if, despite randomization, there is substantial imbalance between group in key covariates (eg race/ethnicity, insurance type or asthma severity.)

Studieoversigt

Status

Ukendt

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Forventet)

195

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Forenede Stater
    • Minnesota
      • Minneapolis, Minnesota, Forenede Stater, 55404
        • Rekruttering
        • Children's Hospitals and Clinics of Minnesota - Emergency Department
        • Kontakt:
          • Anupam B Kharbanda, MD
      • Saint Paul, Minnesota, Forenede Stater
        • Rekruttering
        • Children's Minnesota
        • Kontakt:
          • Anupam Kharbanda, MD

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

4 år til 17 år (Barn)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Caregivers of patients aged 4 - 17 years (inclusive) will be eligible for study participation if they meet the following criteria:

    1. Presentation to the ED with a chief complaint related to an asthma exacerbation such as shortness of breath, respiratory distress, wheezing, etc…
    2. Receive an albuterol treatment in the ED
    3. Previous history of asthma as represented in the medical record or by parental report
    4. Have a cell phone that is able to receive text messages
    5. Able to communicate and provide consent in English or Spanish

Exclusion Criteria:

  • Caregivers of patients will be excluded from this study for the following reasons:

    1. First episode of wheezing
    2. Admitted to the hospital

    3. Co-morbid respiratory disease:

      1. Cystic fibrosis
      2. Bronchiectasis
      3. Pulmonary hypertension
      4. Other chronic lung disease
    4. Current cancer diagnosis
    5. Previous cardiovascular surgery
    6. Inflammatory bowel disease
    7. Sickle Cell disease

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: Control
Subjects receive general, health-related text messages applicable for children with asthma.
Adfærdsmæssigt: General text messages
Subjects received text messages generalized to children with asthma
Eksperimentel: Test group
Subjects receive specific, targeted text messages for post-emergency department discharge asthma care.
Adfærdsmæssigt: Targeted text messages
Subjects received text messages specific to post ED asthma follow-up

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Follow-up care with primary care provider
Tidsramme: 1 week after emergency department discharge
Assessed via text and follow-up call if no response to text message
1 week after emergency department discharge

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Influenza vaccine
Tidsramme: 30 days after emergency department discharge
Assessed via text and follow-up call if no response to text message
30 days after emergency department discharge
Return visit to the emergency department
Tidsramme: 30 days after the inaugural emergency department visit
Assessed via text and follow-up call if no response to text message; Our health record also checked for return visits
30 days after the inaugural emergency department visit

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Children's Hospitals and Clinics of Minnesota

Samarbejdspartnere

HealthPartners Institute

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. oktober 2014

Primær færdiggørelse (Forventet)

1. december 2018

Studieafslutning (Forventet)

1. december 2018

Datoer for studieregistrering

Først indsendt

1. maj 2015

Først indsendt, der opfyldte QC-kriterier

1. maj 2015

Først opslået (Skøn)

6. maj 2015

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

22. november 2017

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

20. november 2017

Sidst verificeret

1. november 2017

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • 1409-082

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med General text messages

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Greece

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

Abonner